Effect of gentamicin dosing interval on efficacy of penicillin or ceftriaxone treatment of experimental endocarditis due to penicillin- susceptible, ceftriaxone-tolerant viridans group streptococci

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 12, 1996, Pages 2901-2903

  Brandt, Claudia M ^a   Warner, Candace B ^a,b   Rouse, Mark S ^a   Steckelberg, James M ^a   Wilson, Walter R ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; GENTAMICIN; PROCAINE PENICILLIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG EFFICACY; INTRAMUSCULAR DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0029826962     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.12.2901     Document Type: Article

References (28)

1. Amsten, G. W., and J. J. Schentag. 1995. Tables of antimicrobial agent pharmacology, p. 492-528. In G. L. Mandell, J. E. Bennett, and R. Dobin (ed.), Principles and practice of infectious diseases, 4th ed. Churchill Livingstone, New York.
2. Bennett, W. M., C. E. Plamp, D. N. Gilbert, R. A. Parker, and G. A. Porter. 1979. The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure. J. Infect. Dis. 140:576-580.
3. Blumer, J. 1991. Pharmacokinetics of ceftriaxone. Hosp. Pract. 26(Suppl. 5): 7-13.
4. Brennan, R. O., and D. T. Durack. 1983. Therapeutic significance of penicillin tolerance in experimental streptococcal endocarditis. Antimicrob. Agents Chemother. 23:273-277.
5. Chapin-Robertson, K., and S. C. Edberg. 1991. Measurements of antibiotics in human body fluids: techniques and significance, p. 295-366. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. The Williams & Wilkins Co., Baltimore.
6. Durack, D. T., and X. X. Beeson. 1972. Experimental bacterial endocarditis. 1. Colonisation of a sterile vegetation. Br. J. Exp. Pathol. 53:44-49.
7. Etienne, J., F. Vandenesch, J. P. Fauvel, M. Coulet, V. Brun, and J. Fleurette. 1989. Susceptibilities to ceftriaxone of streptococcal strains associated with infective endocarditis. Chemotherapy (Basel) 35:355-359.
8. Francioli, P., W. Ruch, D. Stamboulian, and the International Infective Endocarditis Study Group. 1995. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clin. Infect. Dis. 21:1406-1410.
9. Francioli, P. B. 1993. Ceftriaxone and outpatient treatment of infective endocarditis. Infect. Dis. Clin. North Am. 7:97-115.
10. Francioli, P. B., J. Etienne, R. Hoigne, J. P. Thys, and A. Gerber. 1992. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient feasibility. JAMA 267:264-280.
11. Francioli, P. B., and M. P. Glauser. 1993. Synergistic activity of ceftriaxone combined with netilmicin administered once daily for treatment of experimental streptococcal endocarditis. Antimicrob. Agents Chemother. 37:207-212.
12. Garcia Rodriguez, J. F., J. A. Mesias Prego, and D. Dominguez Gomez. 1992. Treatment of endocarditis due to penicillin-susceptible streptococci with a two-week course of ceftriaxone followed by oral amoxicillin. Eur. J. Clin. Microbiol. Infect. Dis. 11:952-953.
13. Garrison, P., and L. Freedman. 1970. Experimental endocarditis. Staphylococcal endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart. Yale J. Biol. Med. 42:394-410.
14. Gavaldà, J., A. Pahissa, B. Almirante, M. Laguarda, E. Crespo, L. Pou, and F. Fernández. 1995. Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin. Antimicrob. Agents Chemother. 39:2098-2103.
15. Holloway, Y., J. Dankert, and J. Hess. 1980. Penicillin tolerance and bacterial endocarditis. Lancet i:589.
16. National Committee for Clinical Laboratory Standards. 1987. Methods for determining bactericidal activity of antimicrobial agents. Proposed guideline M26-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
17. National Committee for Clinical Laboratory Standards. 1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow acrobically. 2nd ed. Approved standard M7-A2. National Committee for Clinical Laboratory Standards, Villanova, Pa.
18. O'Brien, P. C., and M. A. Shampo. 1988. Statistical considerations for performing multiple tests in a single experiment. 2. Comparisons among several therapies. Mayo Clin. Proc. 63:816-820.
19. Prins, J. M., H. R. Bueller, E. J. Kuijper, R. A. Tange, and P. Speelman. 1993. Once versus thrice daily gentamicin in patients with serious infections. Lancet 341:335-339.
20. Pulliam, L., S. Inokuchi, W. K. Hadley, and J. Mills. 1979. Penicillin tolerance in experimental streptococcal endocarditis. Lancet ii:957.
21. Sabath, L. D., N. Wheeler, M. Laverdiere, D. Blazevic, and B. J. Wilkinson. 1977. A new type of penicillin resistance of Staphylococcus aureus. Lancet ii:443-447.
22. Saleh-Mghir, A. C. Cremieux, J. M. Vallois, M. Muffat-Joly, C. Devine, and C. Carbon. 1992. Optimal aminoglycoside dosing regimen for penicillin-tobramycin synergism in experimental Streptococcus adjacens endocarditis. Antimicrob. Agents Chemother. 36:2403-2407.
23. Stamboulian, D., P. Bonvehi, C. Arevalo, R. Bologna, I. Cassetti, V. Scilingo, and E. Efron. Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci. Rev. Infect. Dis. 13(Suppl. 2):160-163.
24. Verpooten, G. A., R. A. Giuliano, L. Verbist, G. Eestermans, and M. E. De Broe. 1989. Once-daily dosing decreases renal accumulation of gentamicin and netilmicin. Clin. Pharmacol. Ther. 45:22-27.
25. Wilson, W. R., and J. E. Geraci. 1985. Treatment of streptococcal infective endocarditis. Am. J. Med. 78(Suppl.6B):128-137.
26. Wilson, W. R., A. W. Karchmer, A. S. Dajani, K. A. Taubert, A. Bayer, D. Kaye, A. L. Bisno, P. Ferrieri, S. T. Shulman, and D. T. Durack. 1995. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci and HACEK microorganisms. JAMA 274:1706-1713.
27. Wilson, W. R., R. L. Thompson, C. J. Wilkowski, J. A. Washington II, E. R. Giuliani, and J. E. Geraci. 1981. Short-term therapy for streptococcal infective endocarditis. Combined intramuscular administration of penicillin and streptomycin. JAMA 245:360-363.
28. Wilson, W. R., O. Zak, and M. A. Sande. 1985. Penicillin therapy for treatment of experimental endocarditis caused by viridans streptococci in animals. J. Infect. Dis. 151:1028-1033.